The Clorox Company (NYSE:CLX) Shares Sold by International Assets Investment Management LLC

International Assets Investment Management LLC decreased its holdings in The Clorox Company (NYSE:CLX - Free Report) by 81.0% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 102,326 shares of the company's stock after selling 436,250 shares during the quarter. Clorox accounts for about 0.8% of International Assets Investment Management LLC's holdings, making the stock its 13th largest holding. International Assets Investment Management LLC owned 0.08% of Clorox worth $16,619,000 as of its most recent SEC filing.

Several other institutional investors also recently bought and sold shares of the business. Prospera Private Wealth LLC purchased a new position in shares of Clorox during the 3rd quarter valued at approximately $27,000. Trifecta Capital Advisors LLC lifted its holdings in Clorox by 139.8% during the second quarter. Trifecta Capital Advisors LLC now owns 223 shares of the company's stock valued at $30,000 after purchasing an additional 130 shares in the last quarter. Continuum Advisory LLC grew its position in shares of Clorox by 300.0% in the third quarter. Continuum Advisory LLC now owns 184 shares of the company's stock valued at $30,000 after purchasing an additional 138 shares during the period. Quarry LP increased its stake in shares of Clorox by 99.1% during the second quarter. Quarry LP now owns 229 shares of the company's stock worth $31,000 after purchasing an additional 114 shares in the last quarter. Finally, Carolina Wealth Advisors LLC purchased a new stake in shares of Clorox during the third quarter worth about $48,000. 78.53% of the stock is owned by institutional investors and hedge funds.

Clorox Trading Up 0.6 %

CLX traded up $1.03 during trading hours on Wednesday, reaching $160.73. The company's stock had a trading volume of 1,051,293 shares, compared to its average volume of 1,080,499. The stock has a market cap of $19.90 billion, a PE ratio of 56.00, a P/E/G ratio of 3.04 and a beta of 0.42. The Clorox Company has a fifty-two week low of $127.60 and a fifty-two week high of $171.37. The company has a debt-to-equity ratio of 11.08, a current ratio of 1.00 and a quick ratio of 0.62. The business's 50-day moving average is $164.64 and its 200-day moving average is $155.33.

Clorox (NYSE:CLX - Get Free Report) last announced its quarterly earnings results on Wednesday, October 30th. The company reported $1.86 EPS for the quarter, beating the consensus estimate of $1.36 by $0.50. The business had revenue of $1.76 billion for the quarter, compared to analyst estimates of $1.64 billion. Clorox had a return on equity of 316.08% and a net margin of 4.78%. The company's quarterly revenue was up 27.0% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.49 EPS. As a group, equities research analysts predict that The Clorox Company will post 6.85 earnings per share for the current fiscal year.

Clorox Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Wednesday, January 29th will be given a $1.22 dividend. This represents a $4.88 dividend on an annualized basis and a yield of 3.04%. The ex-dividend date of this dividend is Wednesday, January 29th. Clorox's payout ratio is 170.03%.

Analysts Set New Price Targets

CLX has been the topic of several research analyst reports. Evercore ISI lowered their price objective on Clorox from $140.00 to $139.00 and set an "underperform" rating on the stock in a report on Monday, October 14th. Jefferies Financial Group upgraded Clorox from a "hold" rating to a "buy" rating and raised their target price for the company from $174.00 to $187.00 in a research report on Tuesday, October 1st. JPMorgan Chase & Co. boosted their price target on Clorox from $148.00 to $174.00 and gave the stock a "neutral" rating in a research report on Friday, October 11th. TD Cowen upgraded Clorox from a "sell" rating to a "hold" rating and raised their price objective for the company from $155.00 to $170.00 in a report on Wednesday, November 6th. Finally, Wells Fargo & Company raised shares of Clorox from an "underweight" rating to an "equal weight" rating and upped their target price for the stock from $155.00 to $157.00 in a report on Tuesday. Four investment analysts have rated the stock with a sell rating, ten have issued a hold rating and one has assigned a buy rating to the company. Based on data from MarketBeat, Clorox has an average rating of "Hold" and a consensus target price of $157.46.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.